Home > A. Molecular pathology > Targeted therapy > Therapeutical antibodies > dostarlimab
dostarlimab
Wednesday 8 June 2022
| WKP |
Definition : Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as a medication for the treatment of cancer. Dostarlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.
